Ataxia-pancytopenia syndrome
| Ataxia-pancytopenia syndrome | |
|---|---|
| Synonyms | Ataxia-pancytopenia syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Ataxia, Pancytopenia, Cerebellar ataxia |
| Complications | Infections, Bleeding disorders |
| Onset | Childhood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Genetic testing, Blood test, Bone marrow biopsy |
| Differential diagnosis | Ataxia-telangiectasia, Fanconi anemia |
| Prevention | N/A |
| Treatment | Supportive care, Blood transfusion, Bone marrow transplant |
| Medication | N/A |
| Prognosis | Variable |
| Frequency | Rare |
| Deaths | N/A |
Ataxia-pancytopenia syndrome is a rare, genetic, neurological disorder characterized by early-onset cerebellar ataxia, associated with hematological abnormalities, including pancytopenia and myelodysplastic syndrome, and a predisposition to developing myeloid leukemia.
Symptoms[edit]
The symptoms of Ataxia-pancytopenia syndrome include:
- Cerebellar ataxia
- Pancytopenia
- Myelodysplastic syndrome
- Predisposition to developing myeloid leukemia
Causes[edit]
Ataxia-pancytopenia syndrome is caused by mutations in the SAMD9L gene. This gene provides instructions for making a protein that is involved in controlling cell growth and division.
Diagnosis[edit]
Diagnosis of Ataxia-pancytopenia syndrome is based on the presence of characteristic signs and symptoms. Genetic testing can confirm the diagnosis.
Treatment[edit]
Treatment of Ataxia-pancytopenia syndrome is focused on managing the symptoms. This may include physical therapy for ataxia and treatment for hematological abnormalities.
Prognosis[edit]
The prognosis for individuals with Ataxia-pancytopenia syndrome varies. Some individuals may have a normal lifespan, while others may have a shortened lifespan due to complications of the disorder.